Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Evaluating traditional loans versus credit builder options helps you determine the best path for credit growth based on your situation.
25,423 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Rambus navigates a cooling memory-chip cycle that could weigh on margins even as AI infrastructure demand remains a k...
Federal regulators are probing George Santos over Kalshi trades linked to his State of the Union attendance, a high p...
Thousands of retirees are receiving demand letters from the Social Security Administration demanding repayment of ove...
A fresh investing approach uncovers lesser-known AI stock ideas beyond the marquee names, highlighting software platf...
Housing advocates warn that proposed HUD funding reductions threaten affordability and housing supply as Congress con...
ASML’s stock rally has outpaced the broader market as AI-driven capex and a tightly controlled EUV backbone push back...
Bitcoin topped in late 2025, then pulled back as macro forces and ETF flows shifted. This piece breaks down why 2027 ...
Ukraine intensified pressure on St. Petersburg with a drone barrage as Putin rejected Kyiv's call for talks. The stri...
Broadcom has faced a stock pullback even as AI-driven revenue climbs. This article digs into the reasons behind the d...
Geopolitical risk, a wary AI sector, and stronger payrolls are reshaping market bets, just as SpaceX readies its IPO ...
Bitcoin faces renewed pressure around the $60,000 zone with on-chain data suggesting more coins moving to exchanges. ...